Investing Profile

Niklas Czeloth

InvestorVC
Executive Director / Investment Manager - Boehringer Ingelheim Venture Fund at Boehringer Ingelheim Venture Fund
Photo of Niklas Czeloth, Managing Director at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Boehringer Ingelheim Network
20 CONNECTIONS
Boehringer Ingelheim Network
20 CONNECTIONS
Boehringer Ingelheim Network
20 CONNECTIONS
Boehringer Ingelheim Network
20 CONNECTIONS
Boehringer Ingelheim Network
20 CONNECTIONS
$3.3M - $17.0M
$8.5M
Executive Director / Investment Manager - Boehringer Ingelheim Venture Fund Boehringer Ingelheim2020 - Present
Leiter Pharmakologie Biotherapeutika (Assoc. Director Pharmacology) Biotest AGPresent
Director Board of Directors In1View PhotographyPresent
Investment Manager - Boehringer Ingelheim Venture Fund Boehringer IngelheimPresent
Director Board of Directors ObulytixPresent
Director Board of Directors GLOX Therapeutics Ltd.Present
Chairman of the Board (Interim) ObulytixPresent
Chairman of the Board (Interim) GLOX Therapeutics Ltd.Present
Chariman of the Board (Interim) Refoxy PharmaPresent
Advisory Board Member Refoxy PharmaPresent
Clinical Pharmacology and Safety Science Lead / Scientific Expert ´Must-win-Modalities´ Boehringer IngelheimPresent
Member of Boehringer Ingelheim´s Immunogenicity Expert Panel Boehringer Ingelheim2014 - 2024
International Project Leader (Oncology, Retinopathy, CNS projects) Boehringer Ingelheim2018 - 2020
Director / Head of Biosciences (Nonclinical / DMPK / Pharmacology) Biosimilars Boehringer Ingelheim2014 - 2018
Project Manager DMPK Biosimilars Boehringer Ingelheim2013 - 2014
Leiter Pharmakologie Biotherapeutika Biotest AG2008 - 2013
Scientist Hannover Medical School2003 - 2007
University Hannover Dipl.Biochem. Biochemistry
Sign in with Google →
Sign in with Google →